EW vs OKE · P/E 47, rev $1.39B vs P/E 15, rev $21.70B
Edwards Lifesciences Corp (EW) versus ONEOK Inc (OKE) — a side-by-side from cached financials, not a winner call.
Edwards Lifesciences Corp (EW) is a medical devices company listed on NYSE.
ONEOK Inc (OKE) is a oil & gas midstream company listed on NYSE.
Latest reported EW revenue for 2024-12-31 was $1.39B. Net income was $385.6M. Revenue was up 2.3% from 2024-09-30 to 2024-12-31. EW currently screens at market cap $49.91B and trailing P/E 46.9.
Latest reported OKE revenue for 2024-12-31 was $21.70B. Net income was $3.11B. Revenue was up 22.7% from 2023-12-31 to 2024-12-31. OKE currently screens at market cap $53.92B and trailing P/E 15.3.
EW currently screens at market cap $49.91B and trailing P/E 46.9. OKE currently screens at market cap $53.92B and trailing P/E 15.3.
Not investment advice. Open the EW and OKE stock pages for the full models.
Not investment advice.